• Ph.D. (2005-2010)-in Chemistry: "Designing, Synthesis and Biological Screening of Peptidomimics as Angiotensin Converting Enzyme Inhibitors". Department of Chemistry, University of Delhi & Institute of Genomics and Integrative Biology (IGIB), CSIR, Delhi.
• M.Sc. (2002-2004)-Organic Chemistry, Miranda House, Department of Chemistry, University of Delhi.
• B.Sc. (1999-2002)-Chemistry (H), Daulat Ram College, Department of Chemistry, University of Delhi.
• National Eligibility Test (NET) - Conducted by Council of Scientific and Industrial Research (CSIR) and University Grant Commission on June 2005.

• Teaching Experience: 8 years (Approx.)
• Worked as Research Scientist in Jubilant Chemsys Pvt. Ltd.
• Working as Assistant Professor in Department of Chemistry, Atma Ram Sanatan Dharma College, University of Delhi, Delhi.

Medicinal Chemistry, Peptide Chemistry & Peptidomimmetics

1. Snehlata, Seth MK, Vats ID, Kumar K, Biswas P, Karar J, Hussain ME, Pasha M, Pasha S. Sulphur Containing Angiotensin Converting Enzyme Inhibitor- 3-Thienylalanine-Ornithyl-Proline Activates Endothelial Function and Expression of Genes Involved in Renin Angiotensin System. J Cardiovasc Pharmacol. 2012 Dec 7.
2. Snehlata*, Hanif K*, Pavar MC, Arif E, Fahim M, Pasha MA, Pasha S. Effect of 3-thienylalanine-ornithine-proline, new sulfur-containing angiotensin-converting enzyme inhibitor on blood pressure and oxidative stress in spontaneously hypertensive rats. J Cardiovasc Pharmacol. (2009) 53(2):145-50. * authors have equal contribution
3. Snehlata, Vats ID, Madhu Chopra, Parbati Biswas, Santosh Pasha. Effect of Varying Chain Length between P₁ and P₁' Position of Tripeptidomimics on Activity of Angiotensin Converting Enzyme Inhibitors. Bioorganic and Medicinal Letters (2009) 19: 4364-4366.
4. Vats ID, Snehlata, Karar J, Nath M, Pasha MAQ, Pasha S. Endogenous Peptide: Met-Enkephalin-Arg-Phe, Differently Regulate Expression of Opioid Receptors on Chronic Treatment. Neuropeptides (2009) 43 (5):355-62.
5. Vats ID, Snehlata, Nath M, Pasha S. Effect of Chronic Intra-Peritoneally Administered Chimeric Peptide of Met-Enkephalin and FMRFa-[D-Ala²]YFa-on Antinociception and Opioid Receptor Regulation. Europeon Journal of Pain. (2010) 14 (3):295e1-9.
6. Vats ID, Snehlata, Ahuti Sharma, Nath M, Pasha S. Modified Chimeric Peptide of Met-Enkephalin and FMRFa-[D-Ala2, p-Cl-Phe4]YFa-Induce Non-Specific Antinociception and Up-regulate Opioid Receptor Expression. European Journal of Pharmacology (2010) 638 (1-3):54-60.
7. Pavar MC, Hanif K, Azam A, Snehlata, Qadar Pasha MA, Pasha S. Structure-activity relationship study between Ornithyl-Proline and Lysyl-Proline based tripeptidomimics as angiotensin-converting enzyme inhibitors. Bioorg Med Chem Lett. (2006) 16(8):2117-21.
8.  Vats ID, Snehlata, Mahendra Nath, Santosh Pasha. Role of C Terminal -RFamide- site of chimeric opioid peptide of Met-enkephalin and FMRFa in antinociception and opioid receptor specificity. (Under revision in Neuropeptides)

PRESENTATIONS:

International Presentations:

1. Effect of 3-Thienylalanine-Ornithine-Proline on L-NAME Induced Hypertension in Rats. Mahesh Kumar Seth, Snehlata, M.Fahim, M.Ejaz Hussain, Santosh Pasha. 14th ISCBC-2010 International Conference on Interplay of Chemical and Biological Sciences: Impact on Health and Environment
2. Structure Activity Relationship of Different Hydrophobic Residues at P₁' Position of Tripeptidomimics as Angiotensin-Converting Enzyme Inhibitors. Snehlata, Mahesh C Pavar, P Biswas, Santosh Pasha. 13th ISCBC-2009 International Conference on Interplay of Chemical and Biological Sciences: Impact on Health and Environment
3. Effect of Hydrophobic Residues at the P₁' Position of Tripeptidomimics on their Angiotensin Converting Enzyme Inhibition Potency. Snehlata, Mahesh Chand Pavar^­, K. Hanif, P. Biswas, Santosh Pasha. Zing International Medicinal Chemistry Conference, 2009.
4. In-Vivo Studies of New Sulphur Containing ACE Inhibitor-3-Thienylalanine-Ornithine-Proline and its Comparison with Captopril on Blood Pressure. Snehlata, Kashif Hanif, M.C. Pavar, P. Biswas, MAQ Pasha, Santosh Pasha. 1st International Conference on Drug Design & Discovery, 2008.

National Presentation:

• Thienylalanine-Ornithine-Proline: new sulphur containing ACE inhibitor   and   its comparison with captopril on ACE inhibition and NO level in SHRs. Snehlata, Kashif Hanif, M.C. Pavar, P. Biswas, MAQ Pasha, Santosh Pasha. 1^st Indian Peptide Symposium, 2007. 

CONFERENCE/SYMPOSIUM ATTENDED:

• Technical Terminology in Science Teaching conducted by MHRD, Deshbandhu College, University of Delhi from October 26-27, 2017
• Participated in Workshop on Molecular Modeling, ARSD, University of Delhi,on 23rd Jan, 2018
• 9^th CRSI National Symposium in Chemistry (NSC-9) 2006.
• 2^nd Indian Peptide Symposium 2009.

MEMBERSHIP:

• Indian Peptide Society.
• Member of Indian Science Congress Association.

AWARDS:

• Awarded 100% travel grant for attending conference in Mexico, from Department of Science and Technology, Govt. of India and Council of Scientific and Industrial Research, Govt. of India.